fda banned bpc 157 FDA's Overreach on Compounded Peptides BPC-157: Experimental Peptide Creates Risk
Description
In contrast, testosterone cypionate has a longer half-life of approximately 8 days, allowing it to provide a sustained testosterone release over a week or more

doi:10.3390/ijms24010554 Preparation and storage Research-only handling information

Evans AJ

This evidence-based approach avoids unnecessary supplementation costs and simplifies the protocol for people who do not need additional b12

The compound has not been submitted for FDA approval
